| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0006-8993(02)03050-0 |
| P698 | PubMed publication ID | 12376176 |
| P50 | author | Mireille Lerner-Natoli | Q118469521 |
| P2093 | author name string | Joël Bockaert | |
| Alain Rougier | |||
| Philippe Coubes | |||
| Arielle Crespel | |||
| Corinne Brana | |||
| Gérard Rondouin | |||
| Marie-Claude Rousset | |||
| Michel Baldy-Moulinier | |||
| P2860 | cites work | Granule cell dispersion in the dentate gyrus of humans with temporal lobe epilepsy | Q28270060 |
| Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB | Q28372135 | ||
| Selective up-regulation of I kappaB-alpha in ischemic penumbra following focal cerebral ischemia | Q28582673 | ||
| A highly sensitive immunofluorescence procedure for analyzing the subcellular distribution of GABAA receptor subunits in the human brain. | Q32020102 | ||
| Cerebral ischemia: gene activation, neuronal injury, and the protective role of antioxidants | Q33991795 | ||
| The role of cytokines and growth factors in seizures and their sequelae | Q34109710 | ||
| NF-kappaB in neuronal plasticity and neurodegenerative disorders | Q34131754 | ||
| Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice | Q35314740 | ||
| NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats | Q35875812 | ||
| Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism | Q36099893 | ||
| Cell death, gliosis, and synaptic remodeling in the hippocampus of epileptic rats. | Q40541842 | ||
| Activation of the nuclear factor-kappaB is a key event in brain tolerance. | Q43653405 | ||
| Global cerebral ischemia activates nuclear factor-kappa B prior to evidence of DNA fragmentation | Q48617866 | ||
| Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain | Q48737439 | ||
| Soman-induced seizures rapidly activate astrocytes and microglia in discrete brain regions | Q48796430 | ||
| Enhancement of immunoreactivity for NF-kappa B in human cerebral infarctions | Q48862181 | ||
| Microglial activation by epileptic activities through the propagation pathway of kainic acid-induced hippocampal seizures in the rat. | Q48891423 | ||
| Enhancement of immunoreactivity for NF-kappa B in the hippocampal formation and cerebral cortex of Alzheimer's disease | Q48912994 | ||
| IL-1-induced iNOS expression in human astrocytes via NF-kappa B. | Q54191934 | ||
| Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. | Q64902232 | ||
| Release of TNF alpha in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage | Q71558788 | ||
| MHC class II expression by microglia in tetanus toxin-induced experimental epilepsy in the rat | Q72377696 | ||
| Kindling modulates the IL-1beta system, TNF-alpha, TGF-beta1, and neuropeptide mRNAs in specific brain regions | Q73472960 | ||
| Decreased nuclear factor-kappaB DNA binding activity following permanent focal cerebral ischaemia in the rat | Q73930892 | ||
| Sequential expression of surface antigens and transcription factor NFkappaB by hippocampal cells in excitotoxicity and experimental epilepsy | Q74163681 | ||
| Elevated levels of interleukin-6 may occur in cerebrospinal fluid from patients with recent epileptic seizures | Q77134905 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| temporal lobe epilepsy | Q616667 | ||
| P304 | page(s) | 159-169 | |
| P577 | publication date | 2002-10-01 | |
| P1433 | published in | Brain Research | Q4955782 |
| P1476 | title | Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis | |
| P478 | volume | 952 |
| Q37300227 | A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta |
| Q89948278 | Aberrant expression of PAR bZIP transcription factors is associated with epileptogenesis, focus on hepatic leukemia factor |
| Q35969710 | Amentoflavone protects hippocampal neurons: anti-inflammatory, antioxidative, and antiapoptotic effects |
| Q36709214 | Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder? |
| Q37087330 | Association study between interleukin 1 beta gene and epileptic disorders: a HuGe review and meta-analysis |
| Q37983788 | Astrocyte immune responses in epilepsy |
| Q37794391 | Astrocytes and epilepsy |
| Q38966132 | Astrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases |
| Q37177095 | Astrocytic Acid-Sensing Ion Channel 1a Contributes to the Development of Chronic Epileptogenesis |
| Q55286730 | Astroglial role in the pathophysiology of status epilepticus: an overview. |
| Q49090389 | Atorvastatin treatment during epileptogenesis in a rat model for temporal lobe epilepsy |
| Q34765321 | Bilateral hippocampal atrophy in temporal lobe epilepsy: effect of depressive symptoms and febrile seizures |
| Q27015612 | Biomarkers of epileptogenesis: psychiatric comorbidities (?) |
| Q40510318 | Brain Inflammation and Seizures |
| Q52095118 | Brain Inflammation in an Infant With Hemimegalencephaly, Escalating Seizures, and Epileptic Encephalopathy. |
| Q93038381 | Calpain activation and neuronal death during early epileptogenesis |
| Q47839769 | Can Neurochemical Changes of Mood Disorders Explain the Increase Risk of Epilepsy or its Worse Seizure Control? |
| Q38047583 | Can neurobiological pathogenic mechanisms of depression facilitate the development of seizure disorders? |
| Q38114855 | Causes of CNS inflammation and potential targets for anticonvulsants |
| Q33611760 | Cellular injury and neuroinflammation in children with chronic intractable epilepsy |
| Q30249189 | Common Mechanisms Underlying Epileptogenesis and the Comorbidities of Epilepsy |
| Q48244586 | Complex alterations in microglial M1/M2 markers during the development of epilepsy in two mouse models |
| Q52647791 | Conflicting Effects of Methylglyoxal and Potential Significance of miRNAs for Seizure Treatment. |
| Q90504691 | Craniectomy and Craniotomy in Traumatic Brain Injury: A Propensity-Matched Analysis of Long-Term Functional and Quality of Life Outcomes |
| Q46124252 | Decreased neurite density within frontostriatal networks is associated with executive dysfunction in temporal lobe epilepsy. |
| Q34659417 | Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. |
| Q90756629 | Depressive, inflammatory, and metabolic factors associated with cognitive impairment in patients with epilepsy |
| Q42104426 | Dynamic Change in Cells Expressing IL-1β in Rat Hippocampus after Status Epilepticus |
| Q47580007 | Epilepsy as a Network Disorder (1): What can we learn from other network disorders such as autistic spectrum disorder and mood disorders? |
| Q37242260 | Epilepsy, cognition, and neuropsychiatry (Epilepsy, Brain, and Mind, part 2) |
| Q48228365 | Expression of adhesion factors induced by epileptiform activity in the endothelium of the isolated guinea pig brain in vitro |
| Q48476054 | Focal neocortical epilepsy affects hippocampal volume, shape, and structural integrity: a longitudinal MRI and immunohistochemistry study in a rat model. |
| Q48104527 | Follow-Up of Peripheral IL-1β and IL-6 and Relation with Apoptotic Death in Drug-Resistant Temporal Lobe Epilepsy Patients Submitted to Surgery. |
| Q35014198 | Frontier of epilepsy research - mTOR signaling pathway |
| Q35046590 | Gabapentin administration reduces reactive gliosis and neurodegeneration after pilocarpine-induced status epilepticus |
| Q35795750 | Gene expression in temporal lobe epilepsy is consistent with increased release of glutamate by astrocytes |
| Q92298477 | Glia and extracellular matrix molecules: What are their importance for the electrographic and MRI changes in the epileptogenic zone? |
| Q55028761 | Histological Characterization of the Irritative Zones in Focal Cortical Dysplasia Using a Preclinical Rat Model. |
| Q53623056 | ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis. |
| Q36567422 | Imaging Brain Inflammation: If We Can See It, Maybe We Can Treat It. |
| Q36061966 | Immune response in the eye following epileptic seizures |
| Q38673807 | Immunity and Inflammation in Epilepsy |
| Q24201788 | Immunomodulatory interventions for focal epilepsy syndromes |
| Q36729229 | Implications of decreased hippocampal neurogenesis in chronic temporal lobe epilepsy. |
| Q48107418 | Increased expression of caspase 2 in experimental and human temporal lobe epilepsy |
| Q37322082 | Increased in vivo expression of an inflammatory marker in temporal lobe epilepsy. |
| Q34427274 | Increased metallothionein I/II expression in patients with temporal lobe epilepsy |
| Q41867461 | Inflammation and epilepsy |
| Q38325826 | Inflammation and epilepsy in the developing brain: clinical and experimental evidence |
| Q41160207 | Inflammation and epilepsy: the foundations for a new therapeutic approach in epilepsy? |
| Q38692603 | Inflammation in Epileptic Encephalopathies. |
| Q37872029 | Inflammation in epilepsy: clinical observations |
| Q37586600 | Inflammation in epileptogenesis after traumatic brain injury. |
| Q44476509 | Inflammatory changes during epileptogenesis and spontaneous seizures in a mouse model of mesiotemporal lobe epilepsy. |
| Q27313143 | Inhibiting cholesterol degradation induces neuronal sclerosis and epileptic activity in mouse hippocampus. |
| Q50133892 | Interactions Between Epilepsy and Plasticity |
| Q64107809 | Interleukin-10 inhibits interleukin-1β production and inflammasome activation of microglia in epileptic seizures |
| Q30500480 | Interleukin-1β biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice |
| Q48719793 | Interleukin-6 levels are increased in temporal lobe epilepsy but not in extra-temporal lobe epilepsy. |
| Q38254682 | Is depression associated with an increased risk of treatment-resistant epilepsy? Research strategies to investigate this question |
| Q48375126 | Kinin B1 and B2 receptors are overexpressed in the hippocampus of humans with temporal lobe epilepsy |
| Q90208054 | Laser microdissection-based microproteomics of the hippocampus of a rat epilepsy model reveals regional differences in protein abundances |
| Q41873454 | Leukocyte-endothelial adhesion mechanisms in epilepsy: cheers and jeers |
| Q39095751 | Matrix Metalloproteinase 9 in Epilepsy: The Role of Neuroinflammation in Seizure Development |
| Q53390275 | Mature astrocytes in the adult human neocortex express the early neuronal marker doublecortin. |
| Q58800556 | Metalloprotease Adam10 suppresses epilepsy through repression of hippocampal neuroinflammation |
| Q93270288 | Microglial phenotypes in the human epileptic temporal lobe |
| Q64973430 | Molecular Mechanism Involved in the Pathogenesis of Early-Onset Epileptic Encephalopathy. |
| Q47111535 | Mycophenolate mofetil prevents the delayed T cell response after pilocarpine-induced status epilepticus in mice |
| Q45084169 | Myoloid-related protein 8, an endogenous ligand of Toll-like receptor 4, is involved in epileptogenesis of mesial temporal lobe epilepsy via activation of the nuclear factor-κB pathway in astrocytes |
| Q38115775 | Neural circuit mechanisms of post-traumatic epilepsy |
| Q92640381 | Neurobiologic properties of mood disorders may have an impact on epilepsy: Should this motivate neurologists to screen for this psychiatric comorbidity in these patients? |
| Q48213087 | Neurodegeneration and Pathology in Epilepsy: Clinical and Basic Perspectives |
| Q37584734 | Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator Protein |
| Q37228255 | Neuronal Injury, Gliosis, and Glial Proliferation in Two Models of Temporal Lobe Epilepsy. |
| Q36228613 | New facets of the neuropathology and molecular profile of human temporal lobe epilepsy |
| Q42624486 | Nuclear factor-kappa B activity regulates brain expression of P-glycoprotein in the kainic acid-induced seizure rats |
| Q36794661 | Opposing actions of hippocampus TNFα receptors on limbic seizure susceptibility |
| Q54989642 | Persistent Protection Against Pathology and Paroxysms by P2X7R Antagonism. |
| Q37238455 | Platelet-activating factor receptor antagonism targets neuroinflammation in experimental epilepsy |
| Q34040405 | Population-level evidence for an autoimmune etiology of epilepsy |
| Q36426301 | Rapid, Coordinate Inflammatory Responses after Experimental Febrile Status Epilepticus: Implications for Epileptogenesis |
| Q36106904 | Recent advances in the neuropathology of focal lesions in epilepsy |
| Q47913847 | Role of Neuroinflammation in Evolution of Childhood Epilepsy |
| Q37040824 | Role of brain inflammation in epileptogenesis |
| Q46375569 | Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling |
| Q27009518 | Targeting inflammation as a therapeutic strategy for drug-resistant epilepsies: an update of new immune-modulating approaches |
| Q35341751 | The influence of epileptic neuropathology and prior peripheral immunity on CNS transduction by rAAV2 and rAAV5. |
| Q37816957 | The role of inflammation in epilepsy |
| Q39150957 | Theiler's murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: Models for multiple sclerosis and epilepsy. |
| Q43116251 | Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures |
| Q48506930 | Tonic glutamate in CA1 of aging rats correlates with phasic glutamate dysregulation during seizure |
| Q37982345 | Understanding the basic mechanisms underlying seizures in mesial temporal lobe epilepsy and possible therapeutic targets: a review |
| Q38162945 | Understanding the spectrum of temporal lobe epilepsy: contributions for the development of individualized therapies |
| Q48397983 | White matter abnormalities associate with type and localization of focal epileptogenic lesions. |
| Q81153321 | [Neurogenesis in the adult brain: the demise of a dogma and the advent of new treatments] |
Search more.